急性冠脉综合征
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study
Sparks JA, Barbhaiya M, Karlson EW et al.
Keywords: Genetics; Methotrexate; Pharmacovigilance; Polyglutamate; Toxicity